Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats

Journal of Neuroscience

Volumn 14, Issue 7, 1994, Pages 4130-4146

  Gratton, Alain ^a,b   Wise, Roy A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Concordia University ^*  (Canada)

Author keywords

chronoamperometry; cocaine; dopamine; drug self administration; nucleus accumbens; reinforcement

Indexed keywords

COCAINE; DOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; HABITUATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBSTANCE ABUSE;

EID: 0028366149     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.14-07-04130.1994     Document Type: Article

References (122)

1. Acquas E, Di Chiara G (1992) Depression of mesolimbic DA transmission and sensitization to morphine during opiate abstinence. J Neurochem 58:1620-1625.
2. Akimoto K, Hamamura T, Otsuki S (1989) Subchronic cocaine treatment enhances cocaine-induced DA efflux, studied by in vivo intracerebral dialysis. Brain Res 490:399-344.
3. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S (1990) Enhanced extracellular DA level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats. Brain Res 507:344-346.
4. Baxter BL, Gluckman MI, Stein L, Scerni RA (1974) Self-injection of apomorphine in the rat: positive reinforcement by a DA receptor stimulant. Pharmacol Biochem Behav 2:387-391.
5. Black J, Belluzzi J, Stein L (1985) Reinforcement delay of one second severely impairs acquisition of brain self-stimulation. Brain Res 359: 113-119.
6. Blackburn JR, Phillips AG, Jakubovic A, Fibiger HC (1989) DA and preparatory behavior: II. A neurochemical analysis. Behav Neurosci 103:15-23.
7. Boja JW, Markham L, Patel A, Uhl G, Kuhar MJ (1992) Expression of a single DA transporter cDNA can confer two cocaine binding sites. Neuroreport 3:247-248.
8. Bozarth MA, Wise RA (1985) Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254:81-83.
9. Brazell MP, Feng J, Kasser RJ, Renner KJ, Moghaddam B, Adams RN (1987) An improved method for Nafion coating carbon fiber electrodes for in vivo electrochemistry. J Neurosci Methods 22:167-172.
10. Brown EE, Fibiger HC (1992) Cocaine-induced conditioned locomotion: absence of associated increases in DA release. Neuroscience 48:621-629.
11. Bunney BS, Walter JR, Roth RH, Aghajanian GK (1973) DAergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
12. Campbell BA, Teghtsoonian R, Williams RA (1961) Activity, weight loss, and survival time of food-deprived rats as a function of age. J Comp Physiol Psychol 54:216-219.
13. Capella P, Ghasemzadeh B, Mitchell K, Adams RN (1990) Nafion-coated carbon fiber electrodes for neurochemical studies in brain tissue. Electroanalysis 2:175-182.
14. Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular DA concentrations preferentially in the NAcc of freely moving rats. Neuroscience 28:653-661.
15. Chang JY, Sawyer SF, Lee R-S, Woodward DJ (1991) Correlation between NAcc neuronal activity and cocaine self-administration behavior in rats. Soc Neurosci Abstr 17:679.
16. Church WH, Justice JB Jr, Byrd LD (1987) Extracellular DA in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur J Pharmacol 139:345-348.
17. Clow DW, Jhamandas K (1989) Characterization of L-glutamate action on the release of endogenous DA from the rat caudate-putamen. J Pharmacol Exp Ther 248:722-728.
18. Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the DA depletion hypothesis. Neurosci Biobehav Rev 9:469-477.
19. Dayton MA, Ewing AG, Wightman RM (1981) Evaluation of amphetamine-induced in vivo electrochemical response. Eur J Pharmacol 75:141-144.
20. de Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the DA receptor blocker pimozide but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31:195-203.
21. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey: a measure of psychological dependence. Psychopharmacologia 16:30-48.
22. Devine DP, Leone P, Wise RA (1993) Surgical preparation of striatal tissue facilitates early sampling in microdialysis and reveals an index of neuronal damage. J Neurochem, in press.
23. Di Chiara G, Imperato A (1988) Drugs of abuse preferentially stimulate DA release in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
24. Dougherty JD, Pickens R (1974) Effects of phenobarbital and SKR 525A on cocaine self-administration in rats. Drug Addict 3:135-143.
25. Einhorn LC, Johansen PA, White FJ (1988) Electrophysiological effects of cocaine in the mesoaccumbens DA system: studies in the ventral tegmental area. J Neurosci 8:100-112.
26. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berlin) 78:204-209.
27. Fibiger HC (1978) Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. Annu Rev Pharmacol Toxicol 18:37-56.
28. Fisher JF, Cho AK (1979) Chemical release of DA from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
29. Fontana DJ, Post RM, Pert A (1991) Conditioned increases in mesolimbic DA overflow by stimuli associated with cocaine. Soc Neurosci Abstr 17:683.
30. Galloway MP (1990) Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse 6:63-72.
31. Gerber GJ, Wise RA (1989) Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav 32:527-531.
32. Gerhardt G, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290:390-395.
33. Gerhardt GA, Friedman M, Brodie MS, Vickroy TW, Gratton A, Hoffer BJ, Rose GM (1989) The effects of cholecystokinin (CCK-8) on DA-containing nerve terminals in the caudate nucleus and NAcc of the anesthetized rat: an in vivo electrochemical study. Brain Res 499:157-163.
34. 3H]acetylcholine release by cocaine. J Pharmacol Exp Ther 263:757-761.
35. Giorguieff MF, Kemel ML, Glowinski J (1977) Presynaptic effect of L-glutamic acid on the release of DA in rat striatal slices. Neurosci Lett 6:73-77.
36. Goeders NE, Smith JE (1983) Cortical DAergic involvement in cocaine reinforcement. Science 221:773-775.
37. Gonon FG, Navarre F, Buda MJ (1984) In vivo monitoring of DA release in the rat brain with differential normal pulse voltammetry. Anal Chem 56:573-575.
38. Grace AA, Bunney BS (1986) Induction of depolarization block in midbrain DA neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
39. Gratton A, Hoffer BJ, Gerhardt GA (1989) In vivo electrochemical determination of monoamine release in the medial prefrontal corta of the rat. Neuroscience 29:57-64.
40. Guerin GF, Goeders NE, Dworkin SI, Smith JE (1984) Intracranial self-administration of DA into the NAcc. Soc Neurosci Abstr 10: 1072.
41. Harker GS (1956) Delay of reward and performance of an instrumental response. J Exp Psychol 51:303-310.
42. 3H)DA in rat brain tissue slices. Biochem Pharmacol 24:847-852.
43. Henriksen SJ, Callaway CW, Negus SS, Koob GF, Miller DE, Berg GI, Friedman LR, Engberg CC (1992) Properties of neurons recorded in the rodent NAcc, in vivo: relationship to behavioral state and heroin self-administration. Soc Neurosci Abstr 18:373.
44. Henry DJ, Greene MA, White FJ (1989) Electrophysiological effects of cocaine in the mesoaccumbens DA system: repeated administration. J Pharmacol Exp Ther 251:833-839.
45. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L (1983) Self-injection of amphetamine directly into the brain. Psychopharmacology (Berlin) 81:158-163.
46. Hurd J, Ungerstedt U (1989) Cocaine: an in vivo microdialysis evaluation of its acute action on DA transmission in rat striatum. Synapse 3:48-54.
47. Hurd JL, Weiss F, Koob GF, Anden N-E, Ungerstedt U (1989) Cocaine reinforcement and extracellular DA overflow in rat NAcc: an in vivo microdialysis study. Brain Res 498:199-203.
48. Hurd YL, Weiss F, Koob GF, Ungerstedt U (1990) The influence of cocaine self-administration on in vivo DA and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett 109:227-233.
49. Iglauer C, Llewellyn ME, Woods JH (1976) Concurrent schedules of cocaine injection in rhesus monkeys: dose variations under independent and non-independent variable-interval procedures. Pharmacol Rev 27:367-383.
50. Imperato A, Mele A, Scrocco MG, Puglisi-Allegra S (1992) Chronic cocaine alters limbic extracellular DA. Neurochemical basis for addiction. Eur J Pharmacol 212:299-300.
51. Johanson CE, Balster RL, Bonese K (1976) Self-administration of psychomotor stimulant drugs: the effects of unlimited access. Pharmacol Biochem Behav 4:45-51.
52. Kalivas PW, Duffy P (1990) Effect of acute and daily cocaine treatment on extracellular DA in the NAcc. Synapse 5:48-58.
53. Kalivas PW, Duffy P (1993) Time course of extracellular DA and behavioral sensitization to cocaine. II. DA perikarya. J Neurosci 13: 276-284.
54. Keefe KA, Zigmond MJ, Abercrombie ED (1992) Extracellular DA in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47:325-332.
55. Kiyatkin EA, Wise RA, Gratton A (1993) Drug- and behavior-associated changes in dopamine-related electrochemical signals duirng intravenous heroin self-administration in rats. Synapse 14:60-72.
56. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
57. Koob GF, Stinus L, Le Moal M, Bloom FE (1989) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135-140.
58. Kosobud AE, Harris GC, Chapin JK (1992) Actions of drugs of abuse on reward-related activity in neurons of the ventral tegmental area and prefrontal cortex in the rat. Soc Neurosci Abstr 18:900.
59. Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationships between locomotor and stereotypy response profiles and caudate and accumbens DA dynamics. J Neurosci 11:2703-2712.
60. Ljungberg T, Apicella P, Schultz W (1992) Responses of monkey DA neurons during learning of behavioral reactions. J Neurophysiol 67: 145-163.
61. Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berlin) 101:262-266.
62. Lyness WH, Moore KE (1983) Increased self-administration of d-amphetamine by rats pretreated with metergoline. Pharmacol Biochem Behav 18:721-724.
63. Lyness WH, Friedle NM, Moore KE (1979) Destruction of DAergic nerve terminals in NAcc: effect on d-amphetamine self-administration. Pharmacol Biochem Behav 11:553-556.
64. Lyness WH, Friedle NM, Moore KE (1981) Increased self-admimstration of d-amphetamine after destruction of 5-hydroxytryptaminergic nerves. Pharmacol Biochem Behav 12:937-941.
65. Markou A, Koob GF (1991) Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
66. Martin-Iverson MT, Szostak C, Fibiger HC (1986) 6-HydroxyDA lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology (Berlin) 88:310-314.
67. McMillen BA (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol Sci 4:429-432.
68. Mereu G, Westfall TC, Wang RY (1985) Modulation of terminal excitability of mesolimbic dopaminergic neurons by D-amphetamine and haloperidol. Brain Res 359:88-96.
69. Miller HH, Shore PA, Clarke DE (1980) In vivo monoamine oxidase inhibition by d-amphetamine. Biochem Pharmacol 29:1347-1354.
70. Mitchell JB, Gratton A (1991) Opioid modulation and sensitization of dopamine release elicited by sexually relevant stimuli: a high-speed chronoamperometric study in freely behaving rats. Brain Res 551: 20-27.
71. Mitchell JB, Gratton A (1992) Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci 12: 3609-3618.
72. Nicolaysen LC, Pan H-T, Justice JB Jr (1988) Extracellular cocaine and DA concentrations are linearly related in rat striatum. Brain Res 456:317-323.
73. Nomikos GG, Damsma G, Wenkstern BA, Fibiger HC (1990) In vivo characterization of locally applied DA uptake inhibitors by striatal microdialysis. Synapse 6:106-112.
74. Pani L, Kuzmin A, Diana M, De-Montis G, Gessa GL (1990) Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol 190:217-221.
75. Parsons LH, Smith AD, Justice JB (1991) Basal extracellular DA is decreased in the rat NAcc during abstinence from chronic cocaine. Synapse 9:60-65.
76. Perin CT (1943) A quantitative investigation of the delay of reinforcement gradient. J Exp Psychol 32:37-51.
77. Pettit HO, Justice JB (1989) DA in the NAcc during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899-904.
78. Pettit HO, Justice JB Jr (1991) Effect of dose on cocaine self-administration behavior and DA levels in the NAcc. Brain Res 539:94-102.
79. Pettit HO, Pan HT, Parsons LH, Justice JB Jr (1990) Extracellular concentrations of cocaine and DA are enhanced during chronic cocaine administration. J Neurochem 55:798-804.
80. Pfaus JG, Damsma G, Nomikos GG, Wenkstern DG, Blaha CD, Phillips AG, Fibiger HC (1990) Sexual behavior enhances central DA transmission in the male rat. Brain Res 530:345-348.
81. Phillips AG, Mora F, Rolls ET (1981) Intracerebral self-admimstration of amphetamine by rhesus monkeys. Neurosci Lett 24:81-86.
82. Phillips AG, Broekkamp CLE, Fibiger HC (1983) Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog Neuropsychopharmacol Biol Psychiatry 7:585-590.
83. Phillips AG, Pfaus JG, Blaha CD (1991) DA and motivated behavior: insights provided by in vivo analyses. In: The mesolimbic DA system: from motivation to action (Willner P, Scheel-Krüger J, eds), pp 199-224. New York: Wiley.
84. Phillips AG, Blaha CD, Pfaus JG, Blackburn JR (1992) Neurobiological correlates of positive emotional states: DA, anticipation and reward. In: International review of studies on emotion (Strongman KT, ed), pp 32-50. New York: Wiley.
85. Pickens R, Thompson T (1971) Characteristics of stimulant reinforcement. In: Stimulus properties of drugs (Thompson T, Pickens R, eds), pp 177-192. New York: Appleton-Century-Crofts.
86. Pothos E, Rada P, Mark GP, Hoebel BG (1991) Chronic morphine increases synaptic DA in the NAcc and naloxone decreases it unless withdrawal is blocked with clonidine. Soc Neurosci Abstr 17:822.
87. Risner ME, Jones BE (1976) Role of noradrenergic and DAergic processes in amphetamine self-administration. Pharmacol Biochem Behav 5:477-482.
88. Ritz MC, Kuhar MJ (1989) Relationship between self-administration and amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017.
89. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on DA transporters are related to self-administration of cocaine. Science 237:1219-1223.
90. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascendng catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615-620.
91. Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-OHDA lesions of the NAcc. Pharmacol Biochem Behav 12:781-787.
92. Robertson GS, Damsma G, Fibiger HC (1991) Characterization of DA release in the substantia nigra by in vivo microdialysis in freely moving rats. J Neurosci 11:2209-2216.
93. Robertson MW, Leslie CA, Bennett JP Jr (1991) Apparent synaptic DA deficiency induced by withdrawal from chronic cocaine treatment. Brain Res 538:337-339.
94. Rosetti ZL, Melis F, Carboni S, Gessa GL (1991) Marked inhibition of DA release: a common neurobiological substrate for abstinence from drugs of abuse. Soc Neurosci Abstr 17:1599.
95. Schenk JO, Miller E, Gaddis E, Adams RN (1982) Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res 253:353-356.
96. Schultz W, Apicella P, Scarnati E, Ljungberg T (1992) Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12:4595-4610.
97. Segal DS, Kuczenski R (1992) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular DA responses in caudate and accumbens. Brain Res 577:351-355.
98. Stewart J, Wise RA (1992) Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction. Psychopharmacology (Berlin) 108:779-784.
99. Strecker RE, Jacobs BL (1985) Substantia nigra DAergic unit activity in behaving cats: effect of arousal on spontaneous discharge and sensory evoked activity. Brain Res 361:339-350.
100. Teitelbaum P (1966) The use of operant methods in the assessment and control of motivational states. In: Operant behaviour: areas of research and application (Honig WK, ed), pp 565-608. New York: Appleton-Century-Crofts.
101. Timmerman W, Dubocovich ML, Westerink BHC, DeVries JB, Tepper PG, Horn AS (1989) The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine. Eur J Pharmacol 166:1-11.
102. Van der Zee P, Koger HS, Gootjes J, Hespe W (1980) Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of DA uptake. Eur J Med Chem Chim Ther 15:363-370.
103. Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal extracellular DA levels in the NAcc are decreased during cocaine withdrawal after unlimited-access self administration. Brain Res 593:314-318.
104. Westerink BHC, Tuntler J, Damsma G, Rollema H, De Vries JB (1987) The use of tetrodotoxin for the characterization of drug-enhanced release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch Pharmacol 336:502-507.
105. Westerink BHC, Hofsteede HM, Damsma G, De Vries JB (1988) The significance of extracellular calcium for the release of DA, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 337:373-378.
106. Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39-87.
107. Wise RA (1987) Intravenous drug self-administration: a special case of positive reinforcement. In: Methods of assessing the reinforcing properties of abused drugs (Bozarth MA, ed), pp 117-141. New York: Springer.
108. Wise RA (1989) The brain and reward. In: The neuropharmacological basis of reward (Liebman JM, Cooper SJ, eds), pp 377-424. New York: Oxford UP.
109. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
110. Wise RA, Rompré P-P (1989) Brain DA and reward. Annu Rev Psychol 40:191-225.
111. Wise RA, Yokel RA, Hansson P, Gerber GJ (1977) Concurrent intracranial self-stimulation and amphetamine self-administration in rats. Pharmacol Biochem Behav 7:459-461.
112. Wise RA, Spindler J, deWit H, Gerber GJ (1978) Neuroleptic-induced "anhedonia" in rats: pimozide blocks the reward quality of food. Science 201:262-264.
113. Wise RA, Murray A, Bozarth MA (1990) Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever-pressing in rats. Psychopharmacology (Berlin) 100:355-360.
114. Woodward DJ, Chang JY, Sawyer SR (1992) Electrophysiological recordings of NAcc neuronal activity during a modified FR-3 schedule for cocaine self-administration. Soc Neurosci Abstr 18:1572.
115. Woolverton WL, Goldberg LI, Ginos J (1984) Intravenous self-administration of DA receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678-683.
116. Yokel RA (1987) Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preferences. In: Methods of assessing the reinforcing properties of abused drugs (Bozarth MA, ed), pp 1-33. New York: Springer.
117. Yokel RA, Pickens R (1973) Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther 187:27-33.
118. Yokel RA, Pickens R (1974) Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia 34:255-264.
119. Yokel RA, Wise RA (1975) Increased lever-pressing for amphetamine after pimozide in rats: implications for a DA theory of reward. Science 187:547-549.
120. Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central DA blockade in rats. Psychopharmacology (Berlin) 48:311-318.
121. Yokel RA, Wise RA (1978) Amphetamine-type reinforcement by DAergic agonists in the rat. Psychopharmacology (Berlin) 58:289-296.
122. Zetterstrom T, Sharp T, Marsden CA, Ungerstedt U (1983) In vivo measurement of DA and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 41:1769-1773.